Watch our Live Healthier, Longer video (right) to explore how a better world for older people is a better world for everyone.
AFAR provides infrastructure support and leadership for three initiatives funded by the National Institute on Aging (NIA).
The AFAR-managed TAME (Targeting Aging with Metformin) Trial will establish a proof-of-concept that aging processes can be treated, just as we treat diseases.
The TAME Trial ultimately seeks the FDA to make aging an "indication" for treatment.
If aging is made an indication, the TAME Trial will mark a paradigm shift: from treating each age-related medical condition separately, to treating these conditions together, by targeting aging per se.
AFAR is grateful for the collaboration and support of our program partners, including:
AFAR is proud to consistently receive the highest ratings from respected charity evaluators
